Skip to content
(Bloomberg) -- He couldn't feed his family. Matilde Alonso knew it was true but couldn't believe it. The pandemic had just hit Guatemala in full force and Alonso, a 34-year-old construction worker, was suddenly jobless.He sat up all alone till late that night, his mind racing, and fought back tears. He had six mouths to feed, no income and no hope of receiving anything beyond the most meager of crisis-support checks -- some $130 -- from the cash-strapped government.Today, Alonso said, breakfast, lunch and dinner all look about the same in his house in El Jocotillo: maybe a tortilla with salt; maybe a tortilla with beans; maybe a bowl of rice and beans. "We used to eat meat. Now, there's no meat. We used to eat chicken. Now, there's no chicken. We used to drink milk. Now, there's no milk." Even bread, he said, is off the menu. For tens of millions...
Sep.28 -- Siemens AG is unleashing a true behemoth that will be behind much of the world’s electricity. Siemens Energy's listing marks the next step in the unwinding of the giant German conglomerate. Bloomberg’s Oliver Sachgau reports on “Bloomberg Markets: European Open.” (Corrects company name in description.)...
Shares in Aquestive Therapeutics (AQST) plunged 37% in Friday’s after-hours trading after the U.S. Food and Drug Administration (FDA) issued a complete response letter (CRL) regarding the New Drug Application for Libervant (diazepam) Buccal Film for management of seizure clusters.The FDA issues a CRL to indicate that the review cycle for an application is complete but the application cannot be approved in its current form.In the CRL, the FDA cited that, in a study submitted by the company with the application, certain weight groups showed a lower drug exposure level than desired.“The company intends to provide to the FDA additional information on PK modeling to demonstrate that dose adjustments will obtain the desired exposure levels” Aquestive stated.There were no other safety, clinical pharmacology/biopharmaceutics or CMC issues identified in the CRL.However, the FDA did also refer to a small number of protocol deviations in blood draws in one of the studies in...
Tesla Inc (NASDAQ: TSLA) has signed a five-year deal with Australia's Piedmont Lithium Limited (NASDAQ: PLL) for the supply of high-purity lithium ore, Reuters reported Sunday.What Happened: Under the agreement, the Elon Musk-led automaker would obtain a third of its requirement of 160,000 tonnes-per-year spodumene concentrate from Piedmont deposits based in North Carolina, according to Reuters.The two companies can reportedly extend the deal for another five years. The agreement mandates that the two companies agree to begin deliveries between July 2022 and July 2023, Piedmont told Reuters.Why It Matters: The Piedmont deal comes at the heels of the automaker's Battery Day, held last week, where Musk revealed that Tesla had received the rights to a 10,000 acre-land for lithium acquisition. At the same event, a new tabless battery design was also unveiled. The 4860 Battery Cell to be brought into high volume production in 2022 would allow electric vehicles to use...
Owner of the famed Las Vegas casino reveals its hand as one of two possible bidders for the UK firm....
(Bloomberg) -- Siemens Energy AG shares declined on debut in Frankfurt, giving the company whose technology is behind roughly one-sixth of the world’s electricity a lower than expected market value.The shares trimmed a drop of as much as 13% to trade down 1.2% to 21.75 euros at 10 a.m.in Frankfurt, after opening at 22.01 euros. That gave the company a market capitalization of around 15.8 billion euros ($18.4 billion), lower than the 17 billion-euro net book value parent Siemens AG gave it ahead of the spinoff.Monday’s listing is the next step in the unwinding of Siemens -- a German conglomerate making a vast array of goods that spans medical scanners, locomotives and gas turbines -- into separate companies better suited to confront their own unique challenges.The sale is taking place at a time of transition toward greener energy sources, which could hit its dominant coal and gas-turbine business and cloud the...
(Bloomberg) -- Billionaires have Davos. For filmmakers, there’s Sundance. For the people who mine and trade and ship everything from iron ore to platinum, there’s London Metal Exchange Week. It’s a blur of symposiums and drinks, with a reliably lavish lunch thrown by JPMorgan Chase & Co. On a balmy October day in 2018, hundreds of guests crossed a courtyard in the shadow of the Bank of England to a medieval guild hall for champagne and sashimi courtesy of the bank and its top metals trader, Mike Nowak.Nowak had plenty to celebrate. His global trading desk at JPMorgan was the powerhouse in futures contracts for gold, silver, platinum and palladium that account for tens of trillions of dollars in transactions annually. In his mid-40s, Nowak had run the precious metals desk for more than a decade. He had a young family, a house outside Manhattan and a seven-bedroom vacation home a few...
